Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Theravance Biopharma KOL Event to Discuss Ampreloxetine’s Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

    Join Theravance Biopharma for a virtual KOL event featuring Horacio Kaufmann, MD, FAAN (Felicia B. Axelrod Professor of Neurology and Professor…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    LifeSci Partners Monthly State of the Biotech Markets: Sector News and Capital Markets Update

    Join us monthly for our Biotech Capital Markets Update featuring an interactive and informative discussion on the current state of the biotechnology…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    Abliva Virtual KOL Event on KL1333 in Primary Mitochondrial Disease

    Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Jasper Therapeutics Asthma KOL Event

    Join Jasper Therapeutics for a virtual KOL event, featuring Joshua A. Boyce, MD, Harvard Medical School who will join company management to…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Virtual 89bio KOL Webinar on the Pegozafermin Opportunity: An Overview of the Advanced MASH and Compensated Cirrhosis Landscape

    Join 89bio for a virtual KOL event featuring expert hepatologist Arun J. Sanyal, MD (Director of the Stravitz-Sanyal Institute for Liver…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    PDS Biotechnology Virtual KOL Event: Updated VERSATILE-002 Phase 2 Trial Results, Unmet Treatment Needs in Advanced Head and Neck Cancer and Planned Triple Combination Trial

    Join PDS Biotechnology for a virtual Key Opinion Leader (KOL) event to discuss positive, updated data from its VERSATILE-002 Phase…
    TIME: 1:30 PM EDT
    LOCATION: Virtual
    View Details

    Palatin Virtual KOL Event – Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance

    Join Palatin Technologies for a virtual KOL event featuring Jesse Richards, DO (Oklahoma State University College of Osteopathic Medicine), who will…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    ASLAN Pharmaceuticals Virtual KOL Event – Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the Potential of Eblasakimab in this Sizable New Market

    Join ASLAN Pharmaceuticals for a virtual KOL Event with Lisa Beck, MD from University of Rochester, Peter Lio, MD from Northwestern University,…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    CytoSorbents Virtual KOL and Analyst-Investor Day: A Review of STAR-T Pivotal Trial Results with DrugSorb-ATR & Real World Experience with Antithrombotic Drug Removal in Europe

    Join CytoSorbents for a virtual KOL and Analyst-Investor Day, featuring Michael J. Mack, MD (Baylor Scott & White Health), C. Michael Gibson,…
    TIME: 11:30 AM EDT
    LOCATION: Virtual
    View Details

    • LifeSci Partners Monthly State of the Biotech Markets: Sector News and Capital Markets Update

    Join us monthly for our Biotech Capital Markets Update featuring an interactive and informative discussion on the current state of the biotechnology…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    Sermonix Pharmaceuticals KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape

    Join Sermonix Pharmaceuticals for a virtual KOL fireside chat, featuring Senthil Damodaran MD, PhD (MD Anderson Cancer Center) and Seth Wander, MD, PhD…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    Tenax Therapeutics LEVEL Setting: The Scientific Rationale for Levosimendan as the First Treatment for PH-HFpEF and the Ongoing Phase 3 LEVEL Study

    Join Tenax Therapeutics for LEVEL Setting, a panel of globally-recognized thought leaders in the field of heart failure, exploring the…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Benitec Biopharma Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy

    Join Benitec Biopharma for a virtual R&D Day, featuring two key opinion leaders who will discuss the clinical symptoms and…
    TIME: 9:00 AM EDT
    LOCATION: Virtual
    View Details

    Cognition Therapeutics KOL Event on the Evolving Landscape in Alzheimer’s Disease

    Join Cognition Therapeutics for a virtual KOL Event, featuring Martin J. Sadowski, MD, PhD, DSci (New York University School of Medicine),…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Chemomab Therapeutics Breaking New Ground: Expert Perspectives on Primary Sclerosing Cholangitis (PSC)

    Join Chemomab for a virtual KOL event, featuring Chris Bowlus, MD (UC Davis Health), Ricky Safer (PSC Partners Seeking a Cure), and Massimo…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Opthea Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration

    Join Opthea Limited, a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, for a…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details